title: Psoriatic arthritis in 2015: Advancement continues in imaging, tight control and new drugs.
authors.affiliation: Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Contrada Macchia Romana, Via Potito Petrone Snc, Potenza 85100, Italy.
authors.forename: Ignazio
authors.initials: I
authors.lastname: Olivieri
authors.affiliation: Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Contrada Macchia Romana, Via Potito Petrone Snc, Potenza 85100, Italy.
authors.forename: Salvatore
authors.initials: S
authors.lastname: D'Angelo
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000188:drug therapy; D019317:Evidence-Based Medicine; D006801:Humans; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D000069549:Ustekinumab / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D013792:Thalidomide; C555450:secukinumab; D000069549:Ustekinumab; C505730:apremilast